Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT03366246Phase 3Completed
Phase 3, randomised, double-blind trial of lidocaine 10% oropharyngeal spray and prilocaine in pain (2 arms), sponsored by Galeno Research Center. Primary endpoint: Pain assessed by means of a visual analog scale at 90 minutes. Started Jun 2014; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT03366246.